408 CONTINUOUS SUBCUTANEOUS INFUSION OF GROWTH HORMONE (CSIGH) IN GROWTH HORMONE DEFICIENCY: FEASIBILITY AND SHORT TERM METABOLIC EFFECTS

Clicks: 292
ID: 113873
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In contrast to the sustained acceleration of growth observed in pituitary hypersecretion of GH, full catch-up growth is rarely attained in GH deficiency with conventional GH Rx (0.1 U/kg IM 3x/wk). Since circulating GH levels are very low for all but 24-30 hr per wk during conventional Rx, we examined the feasibility and short term metabolic effects of CSIGH using a small infusion pump. Fasting levels of glucose (G), insulin (I), free fatty acids (FFA) and oral glucose tolerance were determined in 5 previously untreated deficient children before and after 85 hrs of CSIGH (dose 2.1 μU/kg/hr ∼ 0.3 U/kg/wk). CSIGH maintained serum GH levels at 3-9 ng/ml during the infusion. As shown in the table, CSIGH produced a modest increase in fasting (0 min) G and I. Furthermore, glucose tolerance was impaired despite 2-fold higher I levels (*p
Reference Key
gertner1970pediatric408 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors J Gertner;S Page;W Tamborlane;J Gertner;S Page;W Tamborlane;
Journal Pediatric research
Year 1970
DOI
doi:10.1203/00006450-198104001-00419
URL
https://doi.org/10.1203/00006450-198104001-00419
Keywords
Pediatrics pediatric surgery general medicine/public health

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.